Circulating E-selectin levels and insulin resistance are associated with early stages of atherosclerosis in nonfunctional adrenal incidentaloma

Archives of Endocrinology and Metabolism
Tuncay DelibasiErman Cakal

Abstract

To evaluate circulating E-selectin levels in patients with nonfunctional adrenal incidentaloma (NFA) in relation to insulin resistance and early atherosclerosis. A total of 40 patients with NFA (mean [SD] age: 55.6 [10.7] years; 70% were females) and 35 controls (mean [SD] age: 51.5 [8.1] years; 71.4% were females) selected from age-, gender- and body mass index (BMI)- matched healthy subjects were enrolled. Serum hsCRP, lipid profile, insulin levels and the homeostasis model assessment of insulin resistance (HOMA-IR) were evaluated. High-resolution B-mode ultrasonography was performed. Serum levels of E-selectin were evaluated by enzyme-linked immunosorbent assay. Patients with NFA had significantly higher values for E-selectin (14.9 (4.8) vs. 12.2 (4.1) ng/mL, p < 0.01) and CIMT (0.6 (0.1) vs. 0.5 (0.1) mm, p < 0.05) than controls. Serum E-selectin levels showed a statistically significant association with hsCRP (r = 0.751, p < 0.001), HOMA-IR (r = 0.575, p < 0.001) and CIMT (r = 0.762, p < 0.001). CIMT (Carotid intima media thickness) was increased in patients with NFA patients with NFA were more insulin resistant than controls and statistically significant relationship was found between size of tumor and HOMA-IR (r = 0.361,...Continue Reading

References

Apr 1, 1995·European Journal of Endocrinology·B AmbrosiG Faglia
Dec 1, 1994·Journal of the American College of Cardiology·Y JangE J Topol
Aug 1, 1995·Endocrine Reviews·R T KloosB Shapiro
Nov 1, 1996·Endocrine Research·M ReinckeB Allolio
Mar 24, 1998·Clinical Endocrinology·M TerzoloA Angeli
Apr 19, 2000·The Journal of Clinical Endocrinology and Metabolism·R RossiG Lombardi
Apr 3, 2001·European Journal of Clinical Investigation·M ReinckeK Borm
Nov 10, 2001·The Journal of Clinical Endocrinology and Metabolism·G G GarrapaE Faloia
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Massimo TerzoloAlberto Angeli
Nov 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Libuse TauchmanovàGaetano Lombardi
Mar 5, 2003·Annals of Internal Medicine·Melvin M GrumbachH Samuel Wieand
Apr 15, 2004·Endocrine Reviews·Georg MansmannStefan R Bornstein
Apr 27, 2005·Endocrinology and Metabolism Clinics of North America·Massimo TerzoloAlberto Angeli
Feb 27, 2007·Vascular Health and Risk Management·Helen A LaneJ Stephen Davies
Apr 21, 2007·Metabolism: Clinical and Experimental·Federica ErmeticiBruno Ambrosi
Sep 25, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·B PortaUNKNOWN MIAMI Study Group
Mar 12, 2008·Nature Clinical Practice. Cardiovascular Medicine·Eric de GrootJohn Jp Kastelein
Mar 13, 2008·The Journal of Clinical Endocrinology and Metabolism·Lynnette K NiemanVictor M Montori
Jul 29, 2009·Journal of Endocrinological Investigation·S YenerS Yesil
Aug 4, 2009·World Journal of Surgery·Yesim ErbilSelçuk Ozarmagan
Aug 13, 2009·Journal of Atherosclerosis and Thrombosis·Susumu SakuraiHiroyasu Iso
Apr 9, 2010·The Journal of Clinical Endocrinology and Metabolism·Iacopo ChiodiniAlfredo Scillitani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Muyesser Sayki ArslanTuncay Delibasi
Scandinavian Journal of Clinical and Laboratory Investigation
Serap B SahinFigen K Sahin
© 2021 Meta ULC. All rights reserved